Aasld 2025. Current and active aasld members have the opportunity to peer or self nominate. Review the underlying mechanisms of hepatic fibrosis reversibility and restoration of liver function, and how this can be achieved in patients.
The designations are supported by compelling positive safety and efficacy data from the phase 2 solstice trial, from which the company recently presented new data at aasld. Challenges and opportunities” emerging topic conference (etc) is a comprehensive event designed to explore the latest advancements, challenges, and opportunities in the management of steatotic.